Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level652 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01238055 | Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer | completed | Phase 2 | 116 | Samsung Medical CenterOTHER | 1 | Apr 9, 2013 | clinicaltrials |
| NCT00017043 | BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy | completed | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 1 | Apr 5, 2013 | clinicaltrials |
| Postoperative Chemoradiotherapy With S-1 in Gastric Cancer |
| completed |
| Phase 2 |
| 46 |
| Chonnam National University HospitalOTHER |
| 1 |
| Apr 4, 2013 |
| clinicaltrials |
| NCT01795768 | Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours(FGFR) | unknown | Phase 2 | 48 | Royal Marsden NHS Foundation TrustOTHER | 1 | Mar 15, 2013 | clinicaltrials |
| NCT01659619 | Effect of Erythromycin Before Endoscopy of Patients With Subtotal Gastrectomy (STG), High Risk of Gastric Stasis | completed | Phase 2 | 114 | The Catholic University of KoreaOTHER | 1 | Feb 21, 2013 | clinicaltrials |
| NCT00733616 | Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General Status | completed | Phase 2 | 44 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00004127 | Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach | completed | Phase 2 | 35 | University of ChicagoOTHER | 2 | Feb 11, 2013 | clinicaltrials |
| NCT01787539 | The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric Cancer(STOPEROPCHEM) | unknown | Phase 2 / Phase 3 | 180 | Medical University of LublinOTHER | 1 | Feb 8, 2013 | clinicaltrials |
| NCT00103324 | S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 17, 2013 | clinicaltrials |
| NCT01611506 | Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric Cancer | terminated | Phase 1 / Phase 2 | 1 | Dr Anna Dorothea WagnerOTHER | 1 | Jan 9, 2013 | clinicaltrials |
| NCT00816543 | Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma | completed | Phase 2 | 41 | SanofiINDUSTRY | 1 | Dec 18, 2012 | clinicaltrials |
| NCT01747707 | Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer | unknown | Phase 2 | 40 | Chinese Academy of Medical SciencesOTHER | 1 | Dec 12, 2012 | clinicaltrials |
| NCT01471132 | Sequential HIPEC of Oxaliplatin and Paclitaxel for Gastric Cancer Patients With Peritoneum Metastasis(SHOP-G01) | unknown | Phase 2 | 20 | Peking UniversityOTHER | 1 | Dec 7, 2012 | clinicaltrials |
| NCT00275951 | Cetuximab Plus P-HDFL for the First-line Treatment of Advanced Gastric Cancer(FLAG) | completed | Phase 2 | 39 | National Taiwan University HospitalOTHER | 1 | Nov 16, 2012 | clinicaltrials |
| NCT01718626 | Study Comparing Sequential Therapy of S1+Docetaxel Followed by S1 to Concomitant S1+Docetaxel for Advanced Gastric Cancer | unknown | Phase 2 | 100 | Hebei Tumor HospitalOTHER | 1 | Nov 6, 2012 | clinicaltrials |
| NCT00514020 | Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer | completed | Phase 2 | 33 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT01655641 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery(TMGS) | unknown | Phase 2 / Phase 3 | 118 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT00737373 | Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus Cancer | completed | Phase 2 | 143 | Krankenhaus NordwestOTHER | 1 | Sep 19, 2012 | clinicaltrials |
| NCT00080002 | Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction | terminated | Phase 2 | — | Enzon Pharmaceuticals, Inc.INDUSTRY | 0 | Sep 6, 2012 | clinicaltrials |
| NCT00335959 | S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery | terminated | Phase 2 | 7 | SWOG Cancer Research NetworkNETWORK | 1 | Aug 17, 2012 | clinicaltrials |
| NCT00006081 | Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer | completed | Phase 2 | 37 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT01573468 | Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer(TESEGAST) | unknown | Phase 2 | 580 | Genta IncorporatedINDUSTRY | 3 | Jul 24, 2012 | clinicaltrials |
| NCT01642953 | Early Recovery After Gastric Cancer Surgery | unknown | Phase 2 | 109 | Ajou University School of MedicineOTHER | 1 | Jul 20, 2012 | clinicaltrials |
| NCT01641783 | Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients | unknown | Phase 2 | 40 | Yanqiao ZhangOTHER | 0 | Jul 17, 2012 | clinicaltrials |
| NCT00012363 | S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus | completed | Phase 2 | 61 | SWOG Cancer Research NetworkNETWORK | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00004895 | Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004910 | Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004911 | Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00017212 | DX-8951f in Treating Patients With Metastatic Stomach Cancer | completed | Phase 2 | — | Daiichi SankyoINDUSTRY | 2 | May 16, 2012 | clinicaltrials |
| NCT00004873 | Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer | completed | Phase 2 | — | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT01552980 | Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma(mSOX) | unknown | Phase 2 | 30 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT01558947 | Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric Cancer | unknown | Phase 2 | 2 | Zhejiang Cancer HospitalOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT01095120 | Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer | unknown | Phase 2 | 27 | Genta IncorporatedINDUSTRY | 2 | Mar 15, 2012 | clinicaltrials |
| NCT01348009 | Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 63 | Genta IncorporatedINDUSTRY | 1 | Mar 13, 2012 | clinicaltrials |
| NCT00021047 | Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00002722 | High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer | completed | Phase 2 | 135 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Mar 5, 2012 | clinicaltrials |
| NCT00821912 | TaxXel: Taxotere and Xeloda in Esophageal Cancer(TaxXel) | unknown | Phase 1 / Phase 2 | 93 | Karolinska University HospitalOTHER | 2 | Feb 28, 2012 | clinicaltrials |
| NCT00074009 | Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 14, 2012 | clinicaltrials |
| NCT00952497 | A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer | completed | Phase 2 | 48 | ACT Biotech, IncINDUSTRY | 2 | Feb 8, 2012 | clinicaltrials |
| NCT01528059 | Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II Diabetes | unknown | Phase 2 / Phase 3 | 110 | feng ZhengOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT00661167 | Phase II Study of ABI-007 for Gastric Cancer | completed | Phase 2 | 56 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jan 18, 2012 | clinicaltrials |
| NCT00215995 | Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas | completed | Phase 2 | 21 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 2 | Jan 13, 2012 | clinicaltrials |
| NCT01426646 | S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric Cancer | unknown | Phase 2 | 218 | Kyungpook National University HospitalOTHER | 1 | Jan 5, 2012 | clinicaltrials |
| NCT01491217 | A Study of Oraxol® in Gastric Cancer Patients | unknown | Phase 1 / Phase 2 | 53 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | Dec 13, 2011 | clinicaltrials |
| NCT00985556 | Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer | unknown | Phase 2 | 130 | Yonsei UniversityOTHER | 1 | Oct 20, 2011 | clinicaltrials |
| NCT01016639 | Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer(CORGI) | completed | Phase 1 / Phase 2 | 106 | Lund University HospitalOTHER | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00865982 | Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer(DCXAIOCHARITE) | unknown | Phase 2 | 50 | Charite University, Berlin, GermanyOTHER | 1 | Aug 5, 2011 | clinicaltrials |
| NCT00004233 | S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach | completed | Phase 2 | 65 | SWOG Cancer Research NetworkNETWORK | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00970138 | Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer | completed | Phase 2 / Phase 3 | 141 | Fudan UniversityOTHER | 1 | Jul 12, 2011 | clinicaltrials |
| NCT00287755 | Clinical Trial of Chemosensitivity Test | completed | Phase 2 | 300 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Jun 29, 2011 | clinicaltrials |
Data updated 22 days agoSource updated Apr 9, 2013source: clinicaltrials